The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years-Reference-Cited by-同舟云学术

The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years

Published:1989-02 Issue:2 Volume:71 Page:189-194
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Preisler H. D.,Anderson K.,Rai K.,Cuttner J.,Yates J.,DuPre E.,Holland J. F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1989.tb04253.x/fullpdf

Reference33 articles.

1. K.M. Anderson, and J.R. Anderson (1989 ) Testing the adequacy of an exponential-with-cure model for censored survival data. (In preparation).

2. Short-term treatment for acute myelogenous leukaemia.

3. Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

4. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trials of Liposomes in Children’s Anticancer Therapy: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov;International Journal of Nanomedicine;2022-04

2. Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease;Bone Marrow Transplantation;2021-02-01

3. CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia;Minerva Medica;2020-11

4. CPX-351 (vyxeos) in AML;Leukemia & Lymphoma;2019-09-24

5. Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States;Health and Quality of Life Outcomes;2018-09-21